29 unknown. 29 Phase 2, 7 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 29 | Unknown 29 |
| Phase 1 | 7 | Unknown 7 |
| Phase 3 | 1 | Unknown 1 |
Follow Brain Injuries: new trials by email Literature Review of Brain Injuries trials Research Report on Brain Injuries
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating the Effect of Tranexamic Acid on the Clinical Outcomes in Patients With Traumatic Brain Injury Tranexamic Acid (TXA), Normal saline - Traumatic Brain Injury | Phase 1 / Phase 2 | Unknown | Mansoura University | 90 | 2024-03-25 | 2024-05-10 |
| Safety and Efficacy of ABX-101 in Participants Aged 18 to 50 Years of Age With Moderate to Severe Traumatic Brain Injury ABX-101 1mg, ABX-101 2mg - Traumatic Brain Injury, Cerebral Edema | Phase 2 | Unknown | Abalonex, LLC | 45 | 2023-12-01 | 2023-10-23 |
| Acute Concussion and Melatonin Melatonin 3 MG, Placebo - Concussion, Mild, Concussion, Brain | Phase 2 | Unknown | Children's National Research Institute | 254 | 2023-03-01 | 2024-02-07 |
| Effect of Bevacizumab on Asymptomatic Radiotherapy-induced Brain Injury Bevacizumab - Brain Injuries | Phase 2 | Unknown | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 204 | 2021-11-01 | 2022-03-31 |
| To Evaluate the Effect of Glibenclamide in Reducing Brain Edema of TBI glibenclamide - Traumatic Brain Injury | Phase 1 / Phase 2 | Unknown | Beijing Tiantan Hospital | 76 | 2021-10-22 | 2021-12-08 |
| Complement Inhibition: Attacking the Overshooting Inflammation @Fter Traumatic Brain Injury C1 Inhibitor, Human, Placebo - Traumatic Brain Injury, Trauma, Head | Phase 2 | Unknown | Leiden University Medical Center | 106 | 2021-02-25 | 2021-09-13 |
| Impact of Vitamin C on Biomarkers of Neurologic Injury in Survivors of Cardiac Arrest Vitamin C, Placebo - Heart Arrest, Out-Of-Hospital, Biomarkers | Phase 2 | Unknown | University Medical Centre Maribor | 150 | 2020-10-01 | 2020-09-24 |
| Growth Hormone Replacement Therapy for Retried Professional Football Players Growth Hormone, Placebo - TBI (Traumatic Brain Injury), Concussion, Brain | Phase 2 | Unknown | Center for Neurological Studies | 42 | 2019-10-08 | 2023-02-08 |
| Mood Tracker Smartphone App for Management of Emotional Distress After TBI Mood tracker ratings - Emotional Distress | Phase 2 | Unknown | Memorial Hermann Health System | 126 | 2019-04-23 | 2020-09-02 |
| Autologous Umbilical Cord Blood Treatment of Neonate With CHD Autlogous UCB infusion - Congenital Heart Disease, Brain Injuries | Phase 1 / Phase 2 | Unknown | Sheba Medical Center | 60 | 2019-02-01 | 2021-01-20 |
| Outcomes Mandate National Integration With Cannabis as Medicine Cannabis, Medical, RYAH-Medtech Inhaler - Chronic Pain, Chronic Pain Syndrome | Phase 2 | Unknown | OMNI Medical Services, LLC | 200000 | 2018-12-01 | 2022-06-02 |
| Fibrinogen Concentrate in Isolated Traumatic Brain Injury RiaSTAP Injectable Product - Traumatic Brain Injury, Hemorrhage | Phase 1 / Phase 2 | Unknown | Leila Dehghani | 50 | 2018-10-23 | 2019-02-27 |
| IL-1ra Dose-range Study for Moderate-to-severe TBI Patients Anakinra Prefilled Syringe, Isotonic saline - Traumatic Brain INjury | Phase 2 | Unknown | Adel Helmy | 60 | 2017-10-01 | 2017-05-08 |
| A Trial Evaluating Effects of COMT Inhibition in Patients With Acquired Brain Injury Tolcapone 200 MG, Placebo - Brain Injuries, Brain Injuries, Traumatic | Phase 2 | Unknown | Sheppard Pratt Health System | 16 | 2017-07-20 | 2017-09-06 |
| Autologous Stem Cell Study for Adult TBI (Phase 2b) Placebo Infusion, Autologous BMMNC Infusion - Brain Injuries, Traumatic, Brain Injuries, Acute | Phase 2 | Unknown | The University of Texas Health Science Center, Houston | 37 | 2016-11-21 | 2024-05-09 |
| The Impact of Riboflavin on Sports-related Concussion Riboflavin, Placebo - Sports-related Concussion | Phase 2 | Unknown | University of Virginia | 500 | 2016-08-01 | 2017-08-11 |
| A Study of IBRF Disorders of Consciousness Advanced Care/MultiModal Care Protocol in Severe Disorders of Consciousness Polypharmacy using FDA-approved products, Median Nerve Stimulation (MNS), Nutraceutical Supplementation - Brain Injury | Phase 1 / Phase 2 | Unknown | International Brain Research Foundation | 30 | 2016-03-01 | 2016-09-02 |
| Treatment of Bevacizumab Followed by Steroid in RN Bevacizumab and steroid, Bevacizumab and placebo - Nasopharyngeal Carcinoma, Adverse Effect of Radiation Therapy | Phase 2 | Unknown | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 86 | 2016-01-01 | 2020-09-17 |
| Evaluate the Effects of Tolcapone on Cognitive and Behavioral Dysfunction in Patients With BI and NCD Tolcapone - Brain Injuries, Traumatic, Neurocognitive Disorders | Phase 2 | Unknown | Sheppard Pratt Health System | 100 | 2015-11-01 | 2017-01-19 |
| Partial Blocks of Rectus Femoris and Soleus With Botulinum Toxin Type A (Xeomin®) to Improve Gait in Hemiparesis Placebo injection, Botulinum toxin injection, Placebo injection and botulinum toxin injection - Hemiparesis After Stroke, Traumatic Brain Injury | Phase 2 | Unknown | Assistance Publique - Hôpitaux de Paris | 66 | 2014-12-01 | 2017-04-19 |
Showing 20 of 29. Sign in to see all of them.
Brain Injuries, Traumatic (21) · Brain Concussion (4) · Craniocerebral Trauma (3) · Anxiety Disorders (2) · Depression (2) · Acquired Immunodeficiency Syndrome (1) · Alzheimer Disease (1) · Amyotrophic Lateral Sclerosis (1) · Anemia, Aplastic (1) · Anemia, Sickle Cell (1) · Angioedemas, Hereditary (1) · Autistic Disorder (1) · Bipolar Disorder (1) · Brain Contusion (1)
Brain Diseases (29) · Central Nervous System Diseases (29) · Nervous System Diseases (29) · Wounds and Injuries (29) · Trauma, Nervous System (28) · Craniocerebral Trauma (26) · Pathological Conditions, Signs and Symptoms (7) · Mental Disorders (6) · Wounds, Nonpenetrating (6) · Head Injuries, Closed (4) · Pathologic Processes (4) · Signs and Symptoms (4) · Brain Damage, Chronic (3) · Cardiovascular Diseases (3)
Bevacizumab (2) · Melatonin (2) · Tolcapone (2) · Ascorbic Acid (1) · Botulinum Toxins (1) · Cycloserine (1) · Dexmedetomidine (1) · Epoetin Alfa (1) · Flumazenil (1) · Glyburide (1) · Growth Hormone (1) · Human Growth Hormone (1) · Injections (1) · Interleukin 1 Receptor Antagonist Protein (1) · Ketamine (1)
Sheppard Pratt Health System (2) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (2) · University of Calgary (2) · University of Virginia (2) · Abalonex, LLC (1) · Abela Pharmaceuticals, Inc. (1) · Adel Helmy (1) · Assistance Publique - Hôpitaux de Paris (1) · Beijing Tiantan Hospital (1) · Center for Neurological Studies (1) · Chang Gung Memorial Hospital (1) · Children's National Research Institute (1) · Hadassah Medical Organization (1) · International Brain Research Foundation (1) · Leiden University Medical Center (1)
United States (11) · China (3) · France (3) · Canada (2) · Israel (2) · Egypt (1) · Iran (1) · Netherlands (1) · Slovenia (1) · South Korea (1) · United Kingdom (1)
Robert J Schloesser, MD (2) · Adel Helmy, MA, MB BChir, FRCS, PhD (1) · Andrej Markota, MD, PhD, Assist. Prof. (1) · Charles S Cox, MD (1) · David A Zygun, MD, MSc (1) · Dr. Ryan O Lakin, MD JD (1) · Edward C Nemergfut, MD (1) · Guy Rosenthal, MD (1) · Hyo Seop Ahn, M.D, Ph.D (1) · Karen M Barlow, MB.ChB (1) · Philip A Defina, Ph.D. (1) · Randall R Benson, MD (1) · Tang Yamei, Ph.D (1)
PMID 23771484, PMID 32217739, PMID 32772826, PMID 34438333, PMID 34863258, PMID 40608439